Alcohol

Caution

2 studies · 1 recommendation

Last updated: January 30, 2026

Alcohol – Hypertension
Caution2 studies

Limit alcohol to 2 drinks daily for men, 1 for women to help control blood pressure

Two clinical guidelines—the Hong Kong Reference Framework for Hypertension Care and the ACCF/AHA 2011 Expert Consensus Document—identify alcohol moderation as a key lifestyle modification for blood pressure management. The Hong Kong framework, developed for a population with 27% hypertension prevalence among adults 15 years and older, specifies limits of no more than 2 standard drinks per day for men and 1 drink per day for women. The ACCF/AHA consensus, endorsed by 8 collaborating organizations, reinforces alcohol moderation as part of non-pharmacological management specifically for patients over 65. Both documents position alcohol restriction within broader cardiovascular risk reduction strategies, though neither provides specific effect sizes for alcohol reduction alone on blood pressure outcomes.

Evidence

Authors: Aronow, Wilbert S, Fleg, Jerome J, Pepine, Carl J, Artinian, Nancy Trygar, Bakris, George, Brown, Alan S, Ferdinand, Keith C, Forciea, Mary Ann, Frishman, William H, Jaigobin, Cheryl, Kostis, John B, Mancia, Giuseppi, Oparil, Suzanne, Ortiz, Eduardo, Reisin, Efrain, Rich, Michael W, Schocken, Douglas D, Weber, Michael A, Wesley, Deborah J

Published: September 11, 2007

This expert consensus document from ACCF/AHA and 8 collaborating organizations provides comprehensive guidance on hypertension management in patients over 65 years of age. Lifestyle modifications including alcohol moderation are addressed as components of non-pharmacological blood pressure management strategies for the elderly population.

Authors: Lam, CLK, Ngai, K.H., Lee, J.P.M.

Published: May 1, 2003

The Hong Kong Reference Framework for Hypertension Care establishes alcohol intake limits of no more than 2 drinks per day for men and 1 drink per day for women as part of lifestyle modifications for hypertension management. This clinical guideline was developed based on international evidence and endorsed by stakeholders for Hong Kong's primary care setting, where hypertension is the most common chronic disease with 27% prevalence among those aged 15 years or above. The framework's evidence base draws from studies demonstrating significant cardiovascular risk reductions with blood pressure control.